13F-HR filed by Eagle Health Investments LP
Eagle Health Investments LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 28 holding rows worth $571,789,551.
- Accession
- 0001172661-26-002258
- Filer
- CIK 1842545
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 28 entries on the cover page, a total value of $571,789,551 stated on the cover page (in dollars after the unit check, H1), rows summing to $571,789,551 with VALUE read as dollars as filed, 13F file number 028-20556. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 730,000 | $93,242,900 | dollars as filed | put |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 76,336 | $55,744,364 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 358,500 | $39,671,610 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 224,271 | $36,672,794 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 310,281 | $28,660,656 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 505,809 | $28,573,150 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 121,877 | $24,374,181 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 494,019 | $24,285,974 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 187,413 | $23,100,526 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 412,497 | $21,746,842 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 267,031 | $19,829,722 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 86,650 | $19,819,455 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 179,322 | $18,900,539 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 884,121 | $18,522,335 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 293,152 | $18,395,288 | dollars as filed | |
| FORTREA HLDGS INC COMMON STOCK | 34965K107 | Stock | 1,307,560 | $12,317,215 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 145,816 | $12,145,015 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 483,815 | $12,100,213 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 119,464 | $11,617,874 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 256,269 | $11,588,484 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 2,060,427 | $11,394,161 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 214,291 | $8,511,639 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 238,673 | $8,439,477 | dollars as filed | |
| ATAIBECKLEY INC | 04650F101 | COM SHS | 1,709,359 | $6,051,131 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 90,000 | $2,250,900 | dollars as filed | call |
| Intuitive Surgical,Inc. | 46120E602 | COM | 4,390 | $2,023,746 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 46,300 | $1,395,945 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 37,686 | $413,415 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-002258 | this filing | 2026-05-15 | acceptance time not in the bulk data set |